We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Polyplus-transfection and NIH Sign a Research License Agreement

News   Feb 18, 2014

 
Polyplus-transfection and NIH Sign a Research License Agreement
 
 
Advertisement
 

RELATED ARTICLES

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

Enzyme Has Newly-Discovered Potential To Clear Huntington's Protein

News

Scientists have identified an enzyme that could play a central role in developing a new route of treatment for Huntington's disease.

READ MORE

New Insights Into How Ovarian Cancer Grows and Evolves

News

In a paper published in the journal Cancer Research, researchers provide new insights into how ovarian cancer grows and evolves within a person.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE